CALGB 50801 (Alliance): PET adapted therapy in bulky stage I/II classic Hodgkin lymphoma (cHL).

Ann S. LaCasce,Travis Dockter,Amy S. Ruppert,Lale Kostakoglu,Heiko Schoder,Eric D. Hsi, Jeffrey A. Bogart,Bruce D. Cheson,Nina D. Wagner-Johnston,Jeremy S. Abramson,Kami J. Maddocks,John Paul Leonard,Nancy L. Bartlett

Hematological Oncology（2021）

引用 7|浏览4

暂无评分

摘要

7507Background: Bulky disease is associated with inferior outcomes in patients with early stage cHL. Historically, most patients (pts) receive chemotherapy followed by radiotherapy (RT), which is a...

查看译文

关键词

i/ii classic hodgkin lymphoma,pet adapted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要